Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 566

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1

Haugen, Bryan R., Pacini, Furio, Reiners, Christoph, Schlumberger, Martin, Ladenson, Paul W., Sherman, Steven I., Cooper, David S., Graham, Kathryn E., Braverman, Lewis E., Skarulis, Monica C., Davies, Terry F., DeGroot, Leslie J., Mazzaferri, Ernest L., Daniels, Gilbert H., Ross, Douglas S., Luster, Markus, Samuels, Mary H., Becker, David V., Maxon, Harry R., Cavalieri, Ralph R., Spencer, Carole A., McEllin, Kevin, Weintraub, Bruce D., Ridgway, E. Chester·1999·The Journal of Clinical Endocrinology & Metabolism

Abstract

Recombinant human TSH has been developed to facilitate monitoring for thyroid carcinoma recurrence or persistence without the attendant morbidity of hypothyroidism seen after thyroid hormone withdrawal. The objectives of this study were to compare the effect of administered recombinant human TSH with thyroid hormone withdrawal on the results of radioiodine whole body scanning (WBS) and serum thyroglobulin (Tg) levels. Two hundred and twenty-nine adult patients with differentiated thyroid cancer requiring radioiodine WBS were studied. Radioiodine WBS and serum Tg measurements were performed after administration of recombinant human TSH and again after thyroid hormone withdrawal in each patient. Radioiodine whole body scans were concordant between the recombinant TSH-stimulated and thyroid hormone withdrawal phases in 195 of 220 (89%) patients. Of the discordant scans, 8 (4%) had superior scans after recombinant human TSH administration, and 17 (8%) had superior scans after thyroid hormone withdrawal (P = 0.108). Based on a serum Tg level of 2 ng/mL or more, thyroid tissue or cancer was detected during thyroid hormone therapy in 22%, after recombinant human TSH stimulation in 52%, and after thyroid hormone withdrawal in 56% of patients with disease or tissue limited to the thyroid bed and in 80%, 100%, and 100% of patients, respectively, with metastatic disease. A combination of radioiodine WBS and serum Tg after recombinant human TSH stimulation detected thyroid tissue or cancer in 93% of patients with disease or tissue limited to the thyroid bed and 100% of patients with metastatic disease. In conclusion, recombinant human TSH administration is a safe and effective means of stimulating radioiodine uptake and serum Tg levels in patients undergoing evaluation for thyroid cancer persistence and recurrence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.84.11.6094

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 566

Metadata

Authors
Haugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P. W., Sherman, S. I., Cooper, D. S., Graham, K. E., Braverman, L. E., Skarulis, M. C., Davies, T. F., DeGroot, L. J., Mazzaferri, E. L., Daniels, G. H., Ross, D. S., Luster, M., Samuels, M. H., Becker, D. V., Maxon, H. R., Cavalieri, R. R., Spencer, C. A., McEllin, K., Weintraub, B. D., & Ridgway, E. C.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1999-11-01
Volume
84
Issue
11
Pages
3877-3885
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2126403689
Cited by
566
References
19
FWCI
16.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1. https://app.cochat.ai/papers/10.1210/jcem.84.11.6094
The paper
Haugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P. W., Sherman, S. I., Cooper, D. S., Graham, K. E., Braverman, L. E., Skarulis, M. C., Davies, T. F., DeGroot, L. J., Mazzaferri, E. L., Daniels, G. H., Ross, D. S., Luster, M., Samuels, M. H., Becker, D. V., Maxon, H. R., . . . Ridgway, E. C. (1999). A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.84.11.6094

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.